Anagrelide hydrochloride
| CAS No. | 58579-51-4 | Cat. No. | BCP04920 |
| Name | Anagrelide hydrochloride | ||
| Synonyms | Anagrelide HCl;Agrylin;BL 4162A; BL-4162A; BL4162A;Agrelin; | ||
| Formula | C10H7Cl2N3O.HCl | M. Wt | 292.55 |
| Description | Anagrelide Hydrochloride is the hydrochloride salt of a synthetic quinazoline derivative, Anagrelide Hydrochloride reduces platelet production through a decrease in megakaryocyte maturation. Anagrelide inhibits cyclic AMP phosphodiesterase, as well as ADP- and collagen-induced platelet aggregation. At therapeutic doses, it does not influence white cell counts or coagulation parameters. Anagrelide is used for treatment of essential thrombocythemia to reduce elevated platelet counts and the risk of thrombosis. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | Phosphodiesterase/PDE | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.